The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
A Direct Effect of Hyperinsulinemia on Serum Sex Hormone-Binding Globulin Levels in Obese Women with the Polycystic Ovary Syndrome*
Abstract
To determine whether hyperinsulinemia can directly reduce serum sex hormone-binding globulin (SHBG) levels in obese women with the polycystic ovary syndrome, six obese women with this disorder were studied. Before study, ovarian steroid production was suppressed in each woman by the administration of 7.5 mg of a long-acting GnRH agonist, leuprolide depot, im, on days -56, -28, and 0. This resulted in substantial reductions in serum concentrations of testosterone (from 1.72 +/- 0.29 nmol/L on day -56 to 0.32 +/- 0.09 nmol/L on day 0), non-SHBG-bound testosterone (from 104 +/- 16 pmol/L on day -56 to 19 +/- 5 pmol/L on day 0), androstenedione (from 7.25 +/- 1.65 nmol/L on day -56 to 2.78 +/- 0.94 nmol/L on day 0), estrone (from 371 +/- 71 pmol/L on day -56 to 156 +/- 29 pmol/L on day 0), estradiol (from 235 +/- 26 pmol/L on day -56 to 90 +/- 24 pmol/L on day 0), and progesterone (from 0.28 +/- 0.12 nmol/L on day -56 to 0.08 +/- 0.02 nmol/L on day 0). Serum SHBG levels, however, did not change (18.8 +/- 2.8 nmol/L on day -56 vs. 17.8 +/- 2.6 nmol/L on day 0). While continuing leuprolide treatment, the women were administered oral diazoxide (300 mg/day) for 10 days to suppress serum insulin levels. Diazoxide treatment resulted in suppressed insulin release during a 100-g oral glucose tolerance test (insulin area under the curve, 262 +/- 55 nmol/min.L on day 0 vs. 102 +/- 33 nmol/min.L on day 10; P less than 0.05) and deterioration of glucose tolerance. Serum testosterone, androstenedione, estrone, estradiol, and progesterone levels did not change during combined diazoxide and leuprolide treatment. In contrast, serum SHBG levels rose by 32% from 17.8 +/- 2.6 nmol/L on day 0 to 23.5 +/- 2.0 nmol/L on day 10 (P less than 0.003). Due primarily to the rise in serum SHBG levels, serum non-SHBG-bound testosterone levels fell by 43% from 19 +/- 5 pmol/L on day 0 to 11 +/- 4 pmol/L on day 10 (P = 0.05). These observations suggest that hyperinsulinemia directly reduces serum SHBG levels in obese women with the polycystic ovary syndrome independently of any effect on serum sex steroids.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Hyperinsulinaemia also plays an indirect role in hyperandrogenism by inhibiting hepatic sex hormone-binding globulin (SHBG) production, thus increasing free testosterone (Kiddy et al., 1989;Nestler et al., 1991).”
From Insulin resistance in polycystic ovary syndrome: a systematic review and meta-analysis of euglycaemic–hyperinsulinaemic clamp studies (2016) · cites this paper as Nestler et al., 1991
In the citing paper
“The result of IR is hyperinsulinemia, which has a central role in the pathogenesis of androgen excess in PCOS.”
From From Prediabetes to Type 2 Diabetes Mellitus in Women with Polycystic Ovary Syndrome: Lifestyle and Pharmacological Management (2020) · cites this paper as [6]
Citations
Cites
Morgan, C. R., & Lazarow, A. (1963) · Diabetes · doi:10.2337/diab.12.2.115 · Cited by 2,197
Profound Peripheral Insulin Resistance, Independent of Obesity, in Polycystic Ovary Syndrome
Dunaif, A., Segal, K. R., Futterweit, W., & Dobrjansky, A. (1989) · Diabetes · doi:10.2337/diab.38.9.1165 · Cited by 1,967
Correlation of Hyperandrogenism with Hyperinsulinism in Polycystic Ovarian Disease*
Burghen, G. A., Givens, J. R., & Kitabchi, A. E. (1980) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-50-1-113 · Cited by 919
Insulin resistance in nonobese patients with polycystic ovarian disease
CHANG, R. J., NAKAMURA, R. M., JUDD, H. L., & KAPLAN, S. A. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-57-2-356 · Cited by 704
REVIEW ARTICLE: THE POLYCYSTIC OVARY SYNDROME
Yen, S. S. C. (1980) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1980.tb02132.x · Cited by 697
PLYMATE, S. R., MATEJ, L. A., JONES, R. E., & FRIEDL, K. E. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-67-3-460 · Cited by 693
Self-citationBarbieri, R. L., Makris, A., Randall, R. W., Daniels, G. H., Kistner, R. W., & Ryan, K. J. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-62-5-904 · Cited by 629
NESTLER, J. E., BARLASCINI, C. O., CLORE, J. N., & BLACKARD, W. G. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-66-1-57 · Cited by 414
Self-citationKIDDY, D. S., SHARP, P. S., WHITE, D. M., SCANLON, M. F., MASON, H. D., BRAY, C. S., POLSON, D. W., REED, M. J., & FRANKS, S. (1990) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1990.tb00857.x · Cited by 364
Circulating gonadotropins, estrogens, and androgens in polycystic ovarian disease
DeVane, G. W., Czekala, N. M., Judd, H. L., & Yen, S. S. C. (1975) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(75)90081-2 · Cited by 338
Cited by
Sorted by citations
Items 101–200 of 814
Azziz, R. (2004) · Reproductive BioMedicine Online · doi:10.1016/s1472-6483(10)61644-6 · Cited by 141
Metabolic effects of oral contraceptives in women with polycystic ovary syndrome.
Korytkowski, M. T., Mokan, M., Horwitz, M. J., & Berga, S. L. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.11.7593446 · Cited by 140
Costello, M., Chapman, M., & Conway, U. (2006) · Human Reproduction · doi:10.1093/humrep/dei501 · Cited by 140
Nylander, M., Frøssing, S., Clausen, H. V., Kistorp, C., Faber, J., & Skouby, S. O. (2017) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2017.03.023 · Cited by 139
Diabetes and endometrial cancer in the Iowa women's health study.
Anderson, K. E., Anderson, E. L., Mink, P. J., Hong, C. P., Kushi, L. H., Sellers, T. A., Lazovich, D., & Folsom, A. R. (2001) · PubMed · Cited by 139
Ibanez, L., Potau, N., Zampolli, M., Prat, N., Virdis, R., Vicens-Calvet, E., & Carrascosa, A. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.3.8772605 · Cited by 138
Jayagopal, V., Kilpatrick, E. S., Jennings, P. E., Hepburn, D. A., & Atkin, S. L. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020557 · Cited by 137
Romualdi, D. (2003) · Human Reproduction · doi:10.1093/humrep/deg264 · Cited by 137
The management of insulin resistance in polycystic ovary syndrome
Teede, H. J., Hutchison, S. K., & Zoungas, S. (2007) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2007.08.001 · Cited by 135
Sex Hormone Changes in Morbidly Obese Patients after Vertical Banded Gastroplasty
Bastounis, E., Karayiannakis, A. J., Syrigos, K., Zbar, A. P., Makri, G. G., & Alexiou, D. (1998) · European Surgical Research · doi:10.1159/000008556 · Cited by 131
Glucose and Lipid Metabolism in Small For Gestational Age Infants at 48 Hours of Age
Bazaes, R. A., Salazar, T., Pittaluga, E., Peña, V., Angélica Alegría, O., Íñiguez, G., Ong, K. K., Dunger, D. B., & Verónica Mericq, G. (2003) · PEDIATRICS · doi:10.1542/peds.111.4.804 · Cited by 135
Orlistat Is as Beneficial as Metformin in the Treatment of Polycystic Ovarian Syndrome
Jayagopal, V., Kilpatrick, E. S., Holding, S., Jennings, P. E., & Atkin, S. L. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0176 · Cited by 134
Insulin as an Effector of Human Ovarian and Adrenal Steroid Metabolism
Nestler, J. E., & Strauss, J. F. (1991) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30245-7 · Cited by 132
Self-citationBremer, A. A., & Miller, W. L. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.02.091 · Cited by 135
Jakubowicz, D. J., & Nestler, J. E. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.2.3753 · Cited by 138
Self-citationCheang, K. I., Baillargeon, J., Essah, P. A., Ostlund, R. E., Apridonize, T., Islam, L. Z., & Nestler, J. E. (2008) · Metabolism · doi:10.1016/j.metabol.2008.05.008 · Cited by 130
Self-citationSkeletal Muscle Insulin Resistance in Endocrine Disease
Peppa, Μ., Koliaki, C. C., Nikolopoulos, P., & Raptis, S. (2010) · BioMed Research International · doi:10.1155/2010/527850 · Cited by 129
Patel, A. V., Feigelson, H. S., Talbot, J. T., McCullough, M. L., Rodríguez, C., Patel, R. C., Thun, M. J., & Calle, E. E. (2008) · International Journal of Cancer · doi:10.1002/ijc.23716 · Cited by 127
Xita, N. V., Tsatsoulis, A. A., Chatzikyriakidou, A., & Georgiou, I. A. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030197 · Cited by 127
Harada, M. (2022) · Reproductive Medicine and Biology · doi:10.1002/rmb2.12487 · Cited by 150
Polycystic Ovary Syndrome: Pathophysiology and Therapeutic Opportunities
Dong, J., & Rees, D. A. (2023) · BMJ Medicine · doi:10.1136/bmjmed-2023-000548 · Cited by 123
Drug Insight: insulin-sensitizing drugs in the treatment of polycystic ovary syndrome—a reappraisal
Dunaif, A. E. (2008) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0787 · Cited by 122
Insulin: A Novel Factor in Carcinogenesis
Gupta, K., Krishnaswamy, G. A., Karnad, A. B., & Peiris, A. N. (2002) · The American Journal of the Medical Sciences · doi:10.1097/00000441-200203000-00004 · Cited by 123
Μacut, D., Τζιόμαλος, Κ., Antić, I. B., Bjekić-Macut, J., Katsikis, I., Papadakis, E. P., Andric, Z. G., & Panidis, D. (2016) · Human Reproduction · doi:10.1093/humrep/dew076 · Cited by 123
Insulin sensitivity and antiandrogenic therapy in women with polycystic ovary syndrome
Diamanti‐Kandarakis, E., Mitrakou, A., Hennes, M. M. I., Platanisiotis, D., Kaklas, N., Spina, J., Georgiadou, E., Hoffmann, R. G., Kissebah, A. H., & Raptis, S. A. (1995) · Metabolism · doi:10.1016/0026-0495(95)90062-4 · Cited by 120
Hypoadiponectinemia—Cause or Consequence of Human “Insulin Resistance”?
Cook, J. R., & Semple, R. K. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2286 · Cited by 119
Effects of Gastric Bypass Surgery on Female Reproductive Function
Legro, R. S., Dodson, W. C., Gnatuk, C. L., Estes, S. J., Kunselman, A. R., Meadows, J. W., Kesner, J. S., Krieg, E. F., Rogers, A. M., Haluck, R. S., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2205 · Cited by 119
Chen, J., Lin, P., Tsai, Y.-R., Yang, Y.-C., & Kang, H. (2019) · Cells · doi:10.3390/cells8111318 · Cited by 129
Relationship of Adolescent Polycystic Ovary Syndrome to Parental Metabolic Syndrome
Leibel, N. I., Baumann, E. E., Kocherginsky, M., & Rosenfield, R. L. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1707 · Cited by 118
Cardiovascular Risk in Women With PCOS
Scicchitano, P., Dentamaro, I., Carbonara, R., Bulzis, G., Dachille, A., Caputo, P., Riccardi, R., Locorotondo, M., Mandurino, C., & Ciccone, M. M. (2012) · Intern J Endocrinol Metab · doi:10.5812/ijem.4020 · Cited by 117
Belli, S., Graffigna, M. N., Oneto, A., Otero, P., Schurman, L., & Levalle, O. A. (2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.08.024 · Cited by 117
Baillargeon, J., & Carpentier, A. C. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.12.055 · Cited by 116
Marca, A. L., Egbe, T. O., Morgante, G., Paglia, T., Ciani, A., & Leo, V. D. (2000) · Human Reproduction · doi:10.1093/humrep/15.1.21 · Cited by 119
Patel, A. V., Calle, E. E., Bernstein, L., Wu, A. H., & Thun, M. J. (2003) · Cancer Causes & Control · doi:10.1023/a:1024895613663 · Cited by 114
On the Association Between Valproate and Polycystic Ovary Syndrome
Genton, P., Bauer, J. M., Duncan, S., Taylor, A. E., Balen, A. H., Eberle, A., Pedersen, B., Salas‐Puig, X., & Sauer, M. V. (2001) · Epilepsia · doi:10.1046/j.1528-1157.2001.28899.x · Cited by 114
Imani, B., Eijkemans, M. J. C., de Jong, F. H., Payne, N. N., Bouchard, P., Giudice, L. C., & Fauser, B. C. J. M. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.2.6356 · Cited by 112
Puberty and polycystic ovarian syndrome: the insulin/insulin-like growth factor I hypothesis
Wallach, E. E., Nobels, F. R. E., & Dewailly, D. (1992) · Fertility and Sterility · doi:10.1016/s0015-0282(16)55307-2 · Cited by 112
Panidis, D., Farmakiotis, D., Rousso, D., Kourtis, A., Katsikis, I., & Krassas, G. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.04.043 · Cited by 111
Early Pregnancy Biochemical Predictors of Gestational Diabetes Mellitus
Powe, C. E. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0834-y · Cited by 113
Jones, M. R., Brower, M. A., Xu, N., Cui, J., Mengesha, E., Chen, Y. I., Taylor, K. D., Azziz, R., & Goodarzi, M. O. (2015) · PLoS Genetics · doi:10.1371/journal.pgen.1005455 · Cited by 111
Androgen excess is the key element in polycystic ovary syndrome
Azziz, R. (2003) · Fertility and Sterility · doi:10.1016/s0015-0282(03)00735-0 · Cited by 109
Physical Activity and Risk of Endometrial Cancer: A Population-Based Prospective Cohort Study
Friberg, E., Mantzoros, C. S., & Wolk, A. (2006) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0465 · Cited by 108
The impact of obesity on hormonal parameters in hirsute and nonhirsute women
Bernasconi, D., Monte, P. D., Meozzi, M., Randazzo, M., Marugo, A., Badaracco, B., & Marugo, M. (1996) · Metabolism · doi:10.1016/s0026-0495(96)90202-4 · Cited by 109
Abnormal aminotransferase activity in women with polycystic ovary syndrome
Schwimmer, J. B., Khorram, O., Chiu, V. Y., & Schwimmer, W. B. (2005) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.08.020 · Cited by 106
The use of berberine for women with polycystic ovary syndrome undergoing IVF treatment
An, Y., Sun, Z., Zhang, Y., Liu, B., Guan, Y., & Lu, M. (2014) · Clinical Endocrinology · doi:10.1111/cen.12294 · Cited by 105
Ünlühızarcı, K., Keleştimur, F., Bayram, F., Şahin, Y., & Tutuş, A. (1999) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1999.00786.x · Cited by 104
Effects of metformin on adrenal steroidogenesis in women with polycystic ovary syndrome
Marca, A. L., Morgante, G., Paglia, T., Ciotta, L., Cianci, A., & Leo, V. D. (1999) · Fertility and Sterility · doi:10.1016/s0015-0282(99)00407-0 · Cited by 103
Serum resistin levels in women with polycystic ovary syndrome
Panidis, D., Koliakos, G., Kourtis, A., Farmakiotis, D., Mouslech, T., & Rousso, D. (2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.06.021 · Cited by 104
Panidis, D., Rousso, D., Koliakos, G., Kourtis, A., Katsikis, I., Farmakiotis, D., Votsi, E., & Diamanti‐Kandarakis, E. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2005.11.044 · Cited by 103
Kamenov, Z., & Gateva, A. (2020) · Molecules · doi:10.3390/molecules25235566 · Cited by 100
“Insulin can directly stimulate androgen secretion and/or increase lutein hormone (LH)-induced androgen secretion from the theca-cells [35,36], increase the amplitude of LH pulsatile secretion [34], decrease liver production of sex hormone binding globulin (SHBG) [37] (Figure 1).”
BackgroundInfluentialRole of Oxidative Stress in Polycystic Ovary Syndrome
Lee, J. Y., Baw, C., Gupta, S., Aziz, N., & Agarwal, A. K. (2010) · Current Women s Health Reviews · doi:10.2174/157340410791321336 · Cited by 99
Sir‐Petermann, T., Bárbara Angel, B., Maliqueo, M. A., Carvajal, F., Santos, J. L., & Pérez-Bravo, F. (2002) · Diabetologia · doi:10.1007/s00125-002-0836-3 · Cited by 99
Gut Microbiota in Patients with Polycystic Ovary Syndrome: a Systematic Review
Guo, J., Shao, J., Yang, Y., Niu, X., Liao, J., Zhao, Q. S., Wang, D., Li, S., & Hu, J. (2021) · Reproductive Sciences · doi:10.1007/s43032-020-00430-0 · Cited by 101
Polycystic Ovary Syndrome in Adolescence
Blank, S. K., Helm, K. D., McCartney, C. R., & Marshall, J. C. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1429.005 · Cited by 97
Insulin and the Polycystic Ovary Syndrome
Utiger, R. D. (1996) · New England Journal of Medicine · doi:10.1056/nejm199608293350909 · Cited by 97
Female Gonadal Function before and after Treatment of Acromegaly
Grynberg, M., Salenave, S., Young, J., & Chanson, P. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2815 · Cited by 96
Lipworth, L., Adami, H., Trichopoulos, D., Cartström, K., & Mantzoros, C. S. (1996) · Epidemiology · doi:10.1097/00001648-199601000-00017 · Cited by 96
Polycystic Ovary Syndrome in the Pediatric Population
Bremer, A. A. (2010) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2010.0039 · Cited by 101
Metformin therapy for the reproductive and metabolic consequences of polycystic ovary syndrome
Sam, S., & Ehrmann, D. A. (2017) · Diabetologia · doi:10.1007/s00125-017-4306-3 · Cited by 93
Insulin resistance, insulin‐like growth factor I and breast cancer: A hypothesis
Kazer, R. R. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910620408 · Cited by 92
Glycemic index and glycemic load in endometrial cancer
Augustin, L. S. A., Gallus, S., Bosetti, C., Levi, F., Negri, E., Franceschi, S., Maso, L. D., Jenkins, D. J. A., Kendall, C. W. C., & Vecchia, C. L. (2003) · International Journal of Cancer · doi:10.1002/ijc.11089 · Cited by 92
Burger, H., Nooter, K., Boersma, A. W. M., van Wingerden, K. E., Looijenga, L. H. J., Jochemsen, A. G., & Stoter, G. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990517)81:4 · Cited by 89
Barbieri, R. L., Sluss, P. M., Powers, R. D., McShane, P. M., Vitonis, A. F., Ginsburg, E. S., & Cramer, D. C. (2005) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.07.956 · Cited by 90
Zacchè, M. M., Caputo, L., Filippis, S., Zacchè, G., Dindelli, M., & Ferrari, A. G. (2009) · Gynecological Endocrinology · doi:10.1080/09513590903015544 · Cited by 91
Diabetes Mellitus and Cancer Risk in a Network of Case-Control Studies
Bosetti, C., Rosato, V., Polesel, J., Levi, F., Talamini, R., Montella, M., Negri, E., Tavani, A., Zucchetto, A., Franceschi, S., et al. (2012) · Nutrition and Cancer · doi:10.1080/01635581.2012.676141 · Cited by 91
Access of reproductive steroids to target tissues
Hammond, G. L. (2002) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/s0889-8545(02)00008-6 · Cited by 90
Imani, B. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.2.676 · Cited by 90
Zborowski, J. V., Cauley, J. A., Talbott, E. O., Guzick, D. S., & Winters, S. J. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.10.6902 · Cited by 89
Mingrone, G., Greco, A., Giancaterini, A., Scarfone, A., Castagneto, M., & Pugeat, M. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(01)00667-0 · Cited by 96
Vuguin, P. M., Linder, B. L., Rosenfeld, R. G., Saenger, P. H., & DiMartino-Nardi, J. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.6.5722 · Cited by 89
Tarkun, İ., Çetinarslan, B., Türemen, E., Şahı̇n, T., Cantürk, Z., & Komşuoğlu, B. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.01948 · Cited by 89
Role of cytochrome P450c17 in polycystic ovary syndrome
Qin, K., & Rosenfield, R. L. (1998) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(98)00177-4 · Cited by 91
Relationship between sex hormone-binding globulin levels and features of the metabolic syndrome
Hajamor, S., Després, J., Couillard, C., Lemieux, S., Tremblay, A., Prud’homme, D., & Tchernof, A. (2003) · Metabolism · doi:10.1016/s0026-0495(03)00066-0 · Cited by 86
Cardiometabolic features of polycystic ovary syndrome
Hoffman, L., & Ehrmann, D. A. (2008) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0755 · Cited by 85
Testicular dysfunction in human immunodeficiency virus—infected men
Poretsky, L., Can, S., & Zumoff, B. (1995) · Metabolism · doi:10.1016/0026-0495(95)90250-3 · Cited by 86
Fux Otta, C., Wior, M., Iraci, G. S., Kaplan, R., Torres, D., Gaido, M. I., & Wyse, E. P. (2010) · Gynecological Endocrinology · doi:10.3109/09513590903215581 · Cited by 85
Siemińśka, L., Marek, B., Kos‐Kudła, B., Niedziolka, D., Kajdaniuk, D., Nowak, M., & Głogowska-Szeląg, J. (2004) · Journal of Endocrinological Investigation · doi:10.1007/bf03347474 · Cited by 85
Moran, L., & Norman, R. J. (2004) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2004.05.003 · Cited by 84
Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome
Tso, L. O., Costello, M., Albuquerque, L. E. T., Andriolo, R. B., & Macedo, C. R. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006105.pub4 · Cited by 90
Goulding, A., Taylor, R. W., Gold, E., & Lewis‐Barned, N. (1996) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/64.4.546 · Cited by 83
Polycystic Ovary Syndrome, Obesity and Reproductive Implications
Hirschberg, A. L. (2009) · Women s Health · doi:10.2217/whe.09.39 · Cited by 85
Yılmaz, M., Karakoç, A., Törüner, F. B., Çakır, N., Tıraş, B., Ayvaz, G., & Arslan, M. (2005) · Gynecological Endocrinology · doi:10.1080/09513590500231627 · Cited by 83
Insulin sensitivity in women with polycystic ovary syndrome: relationship to hyperandrogenemia
Rajkhowa, M., Bicknell, J., Jones, M., & Clayton, R. N. (1994) · Fertility and Sterility · doi:10.1016/s0015-0282(16)56633-3 · Cited by 81
Diagnostic value of calculated testosterone indices in the assessment of polycystic ovary syndrome
Hahn, S., Kuehnel, W., Tan, S., Kramer, K., Schmidt, M., Roesler, S., Kimmig, R., Mann, K., & Janssen, O. E. (2007) · Clinical Chemical Laboratory Medicine · doi:10.1515/cclm.2007.031 · Cited by 82
Sex hormone–binding globulin: biomarker and hepatokine?
Simons, P. I. H. G., Valkenburg, O., Stehouwer, C. D. A., & Brouwers, M. C. G. J. (2021) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2021.05.002 · Cited by 82
Acne, Hirsutism, and Alopecia in Adolescent Girls: Clinical Expressions of Androgen Excess
Rosenfield, R. L., & Lucky, A. W. (1993) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30148-8 · Cited by 82
Jakubowicz, D., Barnea, M., Wainstein, J., & Froy, O. (2013) · Clinical Science · doi:10.1042/cs20130071 · Cited by 81
Taylor, A. E. (1998) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70045-1 · Cited by 80
Prevalence of the Metabolic Syndrome in German Women with Polycystic Ovary Syndrome
Hahn, S., Tan, S., Sack, S., Kimmig, R., Quadbeck, B., Mann, K., & Janssen, O. E. (2007) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2007-967093 · Cited by 80
Sex Hormone-Binding Globulin Gene Expression and Insulin Resistance
Winters, S. J., Gogineni, J., Karegar, M., Scoggins, C., Wunderlich, C. A., Baumgartner, R., & Ghooray, D. T. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2640 · Cited by 79
George, S. S. (2003) · Human Reproduction · doi:10.1093/humrep/deg105 · Cited by 79
High-fat diet exposure from pre-pubertal age induces polycystic ovary syndrome (PCOS) in rats
Patel, R., & Shah, G. B. (2017) · Reproduction · doi:10.1530/rep-17-0584 · Cited by 81
Polycystic ovary syndrome and insulin-resistant hyperinsulinemia
Rosenfield, R. L. (2001) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2001.117430 · Cited by 77
Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome
Tso, L. O., Costello, M., Andriolo, R. B., & de Freitas, V. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006105.pub2 · Cited by 78
Yilmaz, M., Biri, A., Karakoç, A., Törüner, F., Bingöl, B., Çakir, N., Tiras, B., Ayvaz, G., & Arslan, M. (2005) · Journal of Endocrinological Investigation · doi:10.1007/bf03345339 · Cited by 77
Haas, D. A., Carr, B. R., & Attia, G. R. (2003) · Fertility and Sterility · doi:10.1016/s0015-0282(02)04800-8 · Cited by 77
Baillargeon, J., Nestler, J. E., Ostlund, R. E., Apridonidze, T., & Diamanti‐Kandarakis, E. (2008) · Human Reproduction · doi:10.1093/humrep/den097 · Cited by 77
Self-citationCardiovascular risk in women with polycystic ovary syndrome
Giallauria, F., Orio, F., Palomba, S., Lombardi, G., Colao, A., & Vigorito, C. (2008) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0b013e32830b58d4 · Cited by 76
Race, Anthropometric Factors, and Stage at Diagnosis of Breast Cancer
Moorman, P. G., Jones, B. A., Millikan, R. C., Hall, I. J., & Newman, B. M. (2001) · American Journal of Epidemiology · doi:10.1093/aje/153.3.284 · Cited by 77
Shpakov, A. O. (2021) · Pharmaceuticals · doi:10.3390/ph14010042 · Cited by 83
Metadata
- Authors
- NESTLER, J. E., POWERS, L. P., MATT, D. W., STEINGOLD, K. A., PLYMATE, S. R., RITTMASTER, R. S., CLORE, J. N., & BLACKARD, W. G.
- Affiliations
- Madigan Army Medical Center (US)
- ORCID
- PLYMATE, STEPHEN R.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1991-01
- Volume
- 72
- Issue
- 1
- Pages
- 83-89
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2008509267
- Cited by
- 815
- References
- 38
- Citations by year
- 2026: 13 · 2025: 22 · 2024: 25 · 2023: 25 · 2022: 28 · 2021: 38 · 2020: 27 · 2019: 25 · 2018: 18 · 2017: 25 · 2016: 25 · 2015: 30 · 2014: 22 · 2013: 27 · 2012: 18
- FWCI
- 10.34
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (DK-18904)
- National Center for Research Resources (RR 00065, M01RR000065)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- hyperinsulinemia, sex hormone-binding globulin, polycystic ovary syndrome, obesity, insulin resistance, diazoxide, leuprolide, GnRH agonist, testosterone, androstenedione, estradiol, estrone, glucose tolerance, insulin secretion, ovarian steroidogenesis, glucose-insulin interaction, insulin sensitivity index, insulin resistance index
- MeSH terms
- Adult, Androstenedione, Diazoxide, Estradiol, Estrone, Female, Glucose Tolerance Test, Humans, Insulin, Insulin Resistance, Gonadotropin-Releasing Hormone, Obesity, Polycystic Ovary Syndrome, Progesterone, Sex Hormone-Binding Globulin, Testosterone, Androstane-3,17-diol, Leuprolide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review